Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant EGIS Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 30. 3. 2020, under the no.: SUKLS110723/2015:

• the decision is partially reversed and the proceedings are terminated  
• the appeal is dismissed and the decision under appeal is partially upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Boehringer Ingelheim International GmbH, Merck Sharp & Dohme B.V. and Novartis Europharm Limited, against the decision of the State Institute for Drug Control from 17. 4. 2020, under the no. SUKLS151561/2014:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Cipla Europe NV, against the decision of the State Institute for Drug Control from 7. 10. 2021, under the no.: SUKLS196911/2021:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Merck Europe B.V. and Teva Pharmaceuticals CR, s.r.o., against the decision of the State Institute for Drug Control from 24. 3. 2021, under the no. SUKLS81849/2014:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 11. 3. 2020, under the no.: SUKLS68059/2017:

• the operative parts 3 and 5 of the decision are reversed and the proceedings are terminated
• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 11. 3. 2020, under the no.: SUKLS68059/2017:

• the operative parts 13b), 14b), 15b), 16b), 17b), 18b), 19b), 20b), 21b), 22b), 23b), 24b), 25b), 26b), 27b), 28b), 29b), 30b), 31b), 32b), 39b), 40b), 41b), 42b), 49b), 50b), 51b), 52b), 53b), 54b), 55b), 56b), 57b), 58b), 59b), 60b), 61b), 62b), 63b), 64b), 65b), 66b) of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal  
  
• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 8. 10. 2019, under the no. SUKLS204192/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Dr. Falk Pharma GmbH and Tillotts Pharma GmbH, against the decision of the State Institute for Drug Control from 10. 12. 2019, under the no.: SUKLS231130/2017:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.